Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of oral eniluracil/fluorouracil in patients with anthracycline-refractory or anthracycline- and taxane-refractory advanced breast cancer.
Skovsgaard T, Davidson NG, Piccart MJ, Richel DJ, Bonneterre J, Cirkel DT, Barton CM; Eniluracil/Fluorouracil Breast Cancer Study Group. Skovsgaard T, et al. Among authors: bonneterre j. Ann Oncol. 2001 Sep;12(9):1255-7. doi: 10.1023/a:1012249630074. Ann Oncol. 2001. PMID: 11697836 Free article. Clinical Trial.
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC).
Awada A, Bondarenko IN, Bonneterre J, Nowara E, Ferrero JM, Bakshi AV, Wilke C, Piccart M; CT4002 study group. Awada A, et al. Among authors: bonneterre j. Ann Oncol. 2014 Apr;25(4):824-831. doi: 10.1093/annonc/mdu025. Ann Oncol. 2014. PMID: 24667715 Free article. Clinical Trial.
Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.
Praga C, Bergh J, Bliss J, Bonneterre J, Cesana B, Coombes RC, Fargeot P, Folin A, Fumoleau P, Giuliani R, Kerbrat P, Hery M, Nilsson J, Onida F, Piccart M, Shepherd L, Therasse P, Wils J, Rogers D. Praga C, et al. Among authors: bonneterre j. J Clin Oncol. 2005 Jun 20;23(18):4179-91. doi: 10.1200/JCO.2005.05.029. J Clin Oncol. 2005. PMID: 15961765
Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group.
Campone M, Roché H, Kerbrat P, Bonneterre J, Romestaing P, Fargeot P, Namer M, Monnier A, Montcuquet P, Goudier MJ, Fumoleau P. Campone M, et al. Among authors: bonneterre j. Ann Oncol. 2005 Aug;16(8):1343-51. doi: 10.1093/annonc/mdi251. Epub 2005 May 19. Ann Oncol. 2005. PMID: 15905306 Free article.
Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group results.
Fumoleau P, Roché H, Kerbrat P, Bonneterre J, Romestaing P, Fargeot P, Namer M, Monnier A, Montcuquet P, Goudier MJ, Luporsi E; French Adjuvant Study Group. Fumoleau P, et al. Among authors: bonneterre j. Ann Oncol. 2006 Jan;17(1):85-92. doi: 10.1093/annonc/mdj034. Epub 2005 Oct 26. Ann Oncol. 2006. PMID: 16251204 Free article.
Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials.
Namer M, Fargeot P, Roché H, Campone M, Kerbrat P, Romestaing P, Monnier A, Luporsi E, Montcuquet P, Bonneterre J; French Adjuvant Study Group. Namer M, et al. Among authors: bonneterre j. Ann Oncol. 2006 Jan;17(1):65-73. doi: 10.1093/annonc/mdj022. Ann Oncol. 2006. PMID: 16361531 Free article. Clinical Trial.
Second consensus on medical treatment of metastatic breast cancer.
Beslija S, Bonneterre J, Burstein H, Cocquyt V, Gnant M, Goodwin P, Heinemann V, Jassem J, Köstler WJ, Krainer M, Menard S, Petit T, Petruzelka L, Possinger K, Schmid P, Stadtmauer E, Stockler M, Van Belle S, Vogel C, Wilcken N, Wiltschke C, Zielinski CC, Zwierzina H. Beslija S, et al. Among authors: bonneterre j. Ann Oncol. 2007 Feb;18(2):215-25. doi: 10.1093/annonc/mdl155. Epub 2006 Jul 10. Ann Oncol. 2007. PMID: 16831851 Free article. Review.
The sequential use of endocrine treatment for advanced breast cancer: where are we?
Barrios C, Forbes JF, Jonat W, Conte P, Gradishar W, Buzdar A, Gelmon K, Gnant M, Bonneterre J, Toi M, Hudis C, Robertson JF. Barrios C, et al. Among authors: bonneterre j. Ann Oncol. 2012 Jun;23(6):1378-86. doi: 10.1093/annonc/mdr593. Epub 2012 Feb 8. Ann Oncol. 2012. PMID: 22317766 Free PMC article. Review.
280 results